News & Media

Take a closer look at what we’re doing across Teva worldwide

Our latest news

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion A...

Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across

Teva Reports Second Quarter 2021 Financial Results

Teva Reports Second Quarter 2021 Financial Results

Teva Announces Changes to Executive Management Team

Teva Announces Changes to Executive Management Team

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 2...

Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 20

Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due...

Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Teva and Bioeq Announce Commercial Partnership for Biosimilar

Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Ja...

Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan f

Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution...

Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live w...

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with R

New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European ...

New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Acade

Feature stories

Discover the world of Teva

Teva: Supporting Pride and the LGBTQ+ Community

Teva: Supporting Pride and the LGBTQ+ Community

Levana Volovsky - Director, Global Regulatory Bridges the Health Equity Gap for Women with MS

Levana Volovsky - Director, Global Regulatory Bridges the Health Equity Gap for Women with MS

Out of the Limelight: Supporting Millions of Non-COVID Patients in Their Journey Back to Healthcare

Out of the Limelight: Supporting Millions of Non-COVID Patients in Their Journey Back to Healthcare

Celebrating Cultural Diversity at Teva

Celebrating Cultural Diversity at Teva

“This ‘invisible pandemic’ is one of the biggest global health challenges”

“This ‘invisible pandemic’ is one of the biggest global health challenges”

Introducing Teva USA’s HBA Rising Stars & Luminary

Introducing Teva USA’s HBA Rising Stars & Luminary

The secret to achieving our new environmental targets? Our people

The secret to achieving our new environmental targets? Our people

The hidden impact of migraine on millions of women

The hidden impact of migraine on millions of women

Media Resources

Media Inquiries

Contact our corporate communications.

Learn more Media Inquiries

Media Kit

Files and resources for media use only

Download Teva Media Kit Media Kit

Financial Reports

View Teva financial news on our global website.

Learn more Financial Reports

Connect with us

Teva Social Media Guidelines.

Learn more Connect with us